Spruce Biosciences Inc (SPRB)

Dec 20, 2024

Neurocrine Biosciences launches Crenessity in USA - The Pharma Letter

Dec 20, 2024

Dec 20, 2024

HC Wainwright Has Bullish Estimate for SPRB FY2024 Earnings - Defense World

Dec 20, 2024

Dec 17, 2024

Spruce Biosciences (NASDAQ:SPRB) Given “Neutral” Rating at HC Wainwright - Defense World

Dec 17, 2024

Dec 16, 2024

Spruce Biosciences (SPRB) Upgraded to Buy: Here's Why - MSN

Dec 16, 2024

Dec 16, 2024

Spruce Biosciences' SWOT analysis: tildacerfont trials shape stock outlook - Investing.com

Dec 16, 2024

Dec 15, 2024

Spruce Biosciences’ (SPRB) Neutral Rating Reiterated at Guggenheim - Defense World

Dec 15, 2024

Dec 14, 2024

FY2024 Earnings Forecast for SPRB Issued By Leerink Partnrs - Defense World

Dec 14, 2024

Dec 13, 2024

Needham & Company LLC Reiterates Buy Rating for Recursion Pharmaceuticals (NASDAQ:RXRX) - Defense World

Dec 13, 2024

Dec 13, 2024

Rigel Pharmaceuticals’ (RIGL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Dec 13, 2024

Dec 13, 2024

Spruce Biosciences (NASDAQ:SPRB) Earns “Market Perform” Rating from Oppenheimer - Defense World

Dec 13, 2024

Dec 13, 2024

Mizuho Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $3.10 - Defense World

Dec 13, 2024

Dec 13, 2024

Spruce Biosciences (NASDAQ:SPRB) Earns “Market Perform” Rating from JMP Securities - Defense World

Dec 13, 2024

Dec 13, 2024

Spruce Biosciences (NASDAQ:SPRB) Earns “Sector Perform” Rating from Royal Bank of Canada - Defense World

Dec 13, 2024

Dec 13, 2024

Telsey Advisory Group Increases Stitch Fix (NASDAQ:SFIX) Price Target to $6.00 - Defense World

Dec 13, 2024

Dec 13, 2024

Sirius XM (NASDAQ:SIRI) Earns “Buy” Rating from Guggenheim - Defense World

Dec 13, 2024

Dec 13, 2024

Wells Fargo & Company Initiates Coverage on Summit Therapeutics (NASDAQ:SMMT) - Defense World

Dec 13, 2024

Dec 13, 2024

Wells Fargo & Company Reaffirms “Equal Weight” Rating for RxSight (NASDAQ:RXST) - Defense World

Dec 13, 2024

Dec 13, 2024

Solid Biosciences (NASDAQ:SLDB) Research Coverage Started at JMP Securities - Defense World

Dec 13, 2024

Dec 13, 2024

Citizens Jmp Downgrades Spruce Biosciences (NASDAQ:SPRB) to Hold - Defense World

Dec 13, 2024

Dec 13, 2024

SPRB stock touches 52-week low at $0.41 amid market challenges - Investing.com Australia

Dec 13, 2024

Dec 12, 2024

Clinical Trials News Live Feed - StockTitan

Dec 12, 2024

Dec 12, 2024

Arnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

Spruce Biosciences downgraded to Market Perform from Outperform at JMP - MSN

Dec 12, 2024

Dec 12, 2024

Spruce Biosciences to wind down investment for genetic disorder drug - MSN

Dec 12, 2024

Dec 12, 2024

JMP Securities Downgrades Spruce Biosciences (SPRB) - MSN

Dec 12, 2024

Dec 12, 2024

SPRB stock touches 52-week low at $0.41 amid market challenges By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

Spruce stock outlook reduced as tildacerfont falls short, company explores alternatives - Investing.com Canada

Dec 11, 2024

Dec 11, 2024

Oppenheimer Downgrades Spruce Biosciences (SPRB) - MSN

Dec 11, 2024

Dec 11, 2024

Spruce Biosciences stock downgraded after trial miss By Investing.com - Investing.com Canada

Dec 11, 2024

Dec 11, 2024

Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Yahoo Finance

Dec 11, 2024

Dec 11, 2024

Spruce Biosciences stock downgraded after trial miss - Investing.com

Dec 11, 2024

Dec 11, 2024

Spruce Biosciences downgraded to Perform from Outperform at Oppenheimer - TipRanks

Dec 11, 2024

Dec 11, 2024

Oppenheimer cuts Spruce Biosciences to perform By Investing.com - Investing.com UK

Dec 11, 2024

Dec 10, 2024

Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - The Bakersfield Californian

Dec 10, 2024

Dec 10, 2024

Congenital Adrenal Hyperplasia Clinical Trials 2024: EMA, - openPR

Dec 10, 2024

Dec 10, 2024

Company News for Dec 10, 2024 - Yahoo Finance

Dec 10, 2024

Dec 10, 2024

Spruce Biosciences Halts CAH Drug Program After Phase 2 Trial Misses Key Endpoint - StockTitan

Dec 10, 2024

Dec 09, 2024

Layoff Tracker: CDMOs Cut Costs With AmplifyBio and Resilience Layoffs - BioSpace

Dec 09, 2024

Dec 06, 2024

UBS Initiates Coverage of Glaukos (GKOS) with Buy Recommendation - MSN

Dec 06, 2024

Dec 05, 2024

Spruce Biosciences' SWOT analysis: tildacerfont trials key for CAH stock By Investing.com - Investing.com UK

Dec 05, 2024

Dec 03, 2024

Spruce Biosciences stock holds potential as Oppenheimer targets upcoming Phase 2b results - Investing.com Australia

Dec 03, 2024

Dec 02, 2024

Spruce Biosciences stock holds potential as Oppenheimer targets upcoming Phase 2b results By Investing.com - Investing.com South Africa

Dec 02, 2024

Nov 27, 2024

PTAB Finds Hormone Treatment Patent Claims Invalid - Law360

Nov 27, 2024

Nov 21, 2024

Spruce Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024

Nov 19, 2024

Supplementary Review: IBEX Limited (IBEX), November 19, 2024 - MSN

Nov 19, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Spruce Biosciences Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Spruce Biosciences Inc (SPRB) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Scholz Advisers Slash German Growth Forecast for Next Year - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

Spruce Biosciences' SWOT analysis: tildacerfont's fate hangs on Q4 trial results - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

EchoStar Q3 Earnings Lag Estimates on Lower Revenues, Stock Down 13% - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

Spruce Biosciences Faces Nasdaq Delisting Threat: Can a Reverse Stock Split Save Its Market Presence? - TipRanks

Nov 13, 2024

Nov 12, 2024

Spruce Biosciences Reports Q3 2024 Earnings and Updates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Should Value Investors Buy Silvercorp Metals (SVM) Stock? - Yahoo Finance

Nov 12, 2024